Congestive Heart Failure (CHF) Treatment Devices Market - Global Outlook and Forecast 2022-2028
Report Code: KNJ1094726 No. of Pages: 70 Category: Medical Devices
Publisher: Date of Publish:
Publisher: Date of Publish:
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
This report contains market size and forecasts of Congestive Heart Failure (CHF) Treatment Devices in global, including the following market information:
Global Congestive Heart Failure (CHF) Treatment Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Congestive Heart Failure (CHF) Treatment Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Congestive Heart Failure (CHF) Treatment Devices companies in 2021 (%)
The global Congestive Heart Failure (CHF) Treatment Devices market was valued at 5128.5 million in 2021 and is projected to reach US$ 6293.2 million by 2028, at a CAGR of 3.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cardiac Resynchronization Therapy (CRT) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Congestive Heart Failure (CHF) Treatment Devices include Abiomed, Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International, Jarvik Heart, LivaNova PLC, Medtronic and ReliantHeart and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Congestive Heart Failure (CHF) Treatment Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Congestive Heart Failure (CHF) Treatment Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Congestive Heart Failure (CHF) Treatment Devices Market Segment Percentages, by Type, 2021 (%)
Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)
Global Congestive Heart Failure (CHF) Treatment Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Congestive Heart Failure (CHF) Treatment Devices Market Segment Percentages, by Application, 2021 (%)
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
Global Congestive Heart Failure (CHF) Treatment Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Congestive Heart Failure (CHF) Treatment Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Congestive Heart Failure (CHF) Treatment Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Congestive Heart Failure (CHF) Treatment Devices revenues share in global market, 2021 (%)
Key companies Congestive Heart Failure (CHF) Treatment Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Congestive Heart Failure (CHF) Treatment Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abiomed
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International
Jarvik Heart
LivaNova PLC
Medtronic
ReliantHeart
Abbott
1 Introduction to Research & Analysis Reports
1.1 Congestive Heart Failure (CHF) Treatment Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Congestive Heart Failure (CHF) Treatment Devices Overall Market Size
2.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size: 2021 VS 2028
2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales: 2017-2028
3 Company Landscape
3.1 Top Congestive Heart Failure (CHF) Treatment Devices Players in Global Market
3.2 Top Global Congestive Heart Failure (CHF) Treatment Devices Companies Ranked by Revenue
3.3 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Companies
3.4 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Companies
3.5 Global Congestive Heart Failure (CHF) Treatment Devices Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Congestive Heart Failure (CHF) Treatment Devices Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Congestive Heart Failure (CHF) Treatment Devices Players in Global Market
3.8.1 List of Global Tier 1 Congestive Heart Failure (CHF) Treatment Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Congestive Heart Failure (CHF) Treatment Devices Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Congestive Heart Failure (CHF) Treatment Devices Market Size Markets, 2021 & 2028
4.1.2 Cardiac Resynchronization Therapy (CRT)
4.1.3 Implantable Cardioverter Defibrillators (ICDs)
4.2 By Type - Global Congestive Heart Failure (CHF) Treatment Devices Revenue & Forecasts
4.2.1 By Type - Global Congestive Heart Failure (CHF) Treatment Devices Revenue, 2017-2022
4.2.2 By Type - Global Congestive Heart Failure (CHF) Treatment Devices Revenue, 2023-2028
4.2.3 By Type - Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share, 2017-2028
4.3 By Type - Global Congestive Heart Failure (CHF) Treatment Devices Sales & Forecasts
4.3.1 By Type - Global Congestive Heart Failure (CHF) Treatment Devices Sales, 2017-2022
4.3.2 By Type - Global Congestive Heart Failure (CHF) Treatment Devices Sales, 2023-2028
4.3.3 By Type - Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share, 2017-2028
4.4 By Type - Global Congestive Heart Failure (CHF) Treatment Devices Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Congestive Heart Failure (CHF) Treatment Devices Market Size, 2021 & 2028
5.1.2 Left Ventricular Assist Device (LVAD)
5.1.3 Right Ventricular Assist Device (RVAD)
5.1.4 Biventricular Assist Device (BIVAD)
5.2 By Application - Global Congestive Heart Failure (CHF) Treatment Devices Revenue & Forecasts
5.2.1 By Application - Global Congestive Heart Failure (CHF) Treatment Devices Revenue, 2017-2022
5.2.2 By Application - Global Congestive Heart Failure (CHF) Treatment Devices Revenue, 2023-2028
5.2.3 By Application - Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share, 2017-2028
5.3 By Application - Global Congestive Heart Failure (CHF) Treatment Devices Sales & Forecasts
5.3.1 By Application - Global Congestive Heart Failure (CHF) Treatment Devices Sales, 2017-2022
5.3.2 By Application - Global Congestive Heart Failure (CHF) Treatment Devices Sales, 2023-2028
5.3.3 By Application - Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share, 2017-2028
5.4 By Application - Global Congestive Heart Failure (CHF) Treatment Devices Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Congestive Heart Failure (CHF) Treatment Devices Market Size, 2021 & 2028
6.2 By Region - Global Congestive Heart Failure (CHF) Treatment Devices Revenue & Forecasts
6.2.1 By Region - Global Congestive Heart Failure (CHF) Treatment Devices Revenue, 2017-2022
6.2.2 By Region - Global Congestive Heart Failure (CHF) Treatment Devices Revenue, 2023-2028
6.2.3 By Region - Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share, 2017-2028
6.3 By Region - Global Congestive Heart Failure (CHF) Treatment Devices Sales & Forecasts
6.3.1 By Region - Global Congestive Heart Failure (CHF) Treatment Devices Sales, 2017-2022
6.3.2 By Region - Global Congestive Heart Failure (CHF) Treatment Devices Sales, 2023-2028
6.3.3 By Region - Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Congestive Heart Failure (CHF) Treatment Devices Revenue, 2017-2028
6.4.2 By Country - North America Congestive Heart Failure (CHF) Treatment Devices Sales, 2017-2028
6.4.3 US Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.4.4 Canada Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.4.5 Mexico Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Congestive Heart Failure (CHF) Treatment Devices Revenue, 2017-2028
6.5.2 By Country - Europe Congestive Heart Failure (CHF) Treatment Devices Sales, 2017-2028
6.5.3 Germany Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.5.4 France Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.5.5 U.K. Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.5.6 Italy Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.5.7 Russia Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.5.8 Nordic Countries Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.5.9 Benelux Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Congestive Heart Failure (CHF) Treatment Devices Revenue, 2017-2028
6.6.2 By Region - Asia Congestive Heart Failure (CHF) Treatment Devices Sales, 2017-2028
6.6.3 China Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.6.4 Japan Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.6.5 South Korea Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.6.6 Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.6.7 India Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Congestive Heart Failure (CHF) Treatment Devices Revenue, 2017-2028
6.7.2 By Country - South America Congestive Heart Failure (CHF) Treatment Devices Sales, 2017-2028
6.7.3 Brazil Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.7.4 Argentina Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales, 2017-2028
6.8.3 Turkey Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.8.4 Israel Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.8.5 Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
6.8.6 UAE Congestive Heart Failure (CHF) Treatment Devices Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Abiomed
7.1.1 Abiomed Corporate Summary
7.1.2 Abiomed Business Overview
7.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Major Product Offerings
7.1.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales and Revenue in Global (2017-2022)
7.1.5 Abiomed Key News
7.2 Berlin Heart GmbH
7.2.1 Berlin Heart GmbH Corporate Summary
7.2.2 Berlin Heart GmbH Business Overview
7.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Major Product Offerings
7.2.4 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales and Revenue in Global (2017-2022)
7.2.5 Berlin Heart GmbH Key News
7.3 Biotronik SE & Co. KG
7.3.1 Biotronik SE & Co. KG Corporate Summary
7.3.2 Biotronik SE & Co. KG Business Overview
7.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Major Product Offerings
7.3.4 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales and Revenue in Global (2017-2022)
7.3.5 Biotronik SE & Co. KG Key News
7.4 Boston Scientific Corporation
7.4.1 Boston Scientific Corporation Corporate Summary
7.4.2 Boston Scientific Corporation Business Overview
7.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Major Product Offerings
7.4.4 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales and Revenue in Global (2017-2022)
7.4.5 Boston Scientific Corporation Key News
7.5 HeartWare International
7.5.1 HeartWare International Corporate Summary
7.5.2 HeartWare International Business Overview
7.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Major Product Offerings
7.5.4 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales and Revenue in Global (2017-2022)
7.5.5 HeartWare International Key News
7.6 Jarvik Heart
7.6.1 Jarvik Heart Corporate Summary
7.6.2 Jarvik Heart Business Overview
7.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Major Product Offerings
7.6.4 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales and Revenue in Global (2017-2022)
7.6.5 Jarvik Heart Key News
7.7 LivaNova PLC
7.7.1 LivaNova PLC Corporate Summary
7.7.2 LivaNova PLC Business Overview
7.7.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Major Product Offerings
7.7.4 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales and Revenue in Global (2017-2022)
7.7.5 LivaNova PLC Key News
7.8 Medtronic
7.8.1 Medtronic Corporate Summary
7.8.2 Medtronic Business Overview
7.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Major Product Offerings
7.8.4 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales and Revenue in Global (2017-2022)
7.8.5 Medtronic Key News
7.9 ReliantHeart
7.9.1 ReliantHeart Corporate Summary
7.9.2 ReliantHeart Business Overview
7.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Major Product Offerings
7.9.4 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales and Revenue in Global (2017-2022)
7.9.5 ReliantHeart Key News
7.10 Abbott
7.10.1 Abbott Corporate Summary
7.10.2 Abbott Business Overview
7.10.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Major Product Offerings
7.10.4 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales and Revenue in Global (2017-2022)
7.10.5 Abbott Key News
8 Global Congestive Heart Failure (CHF) Treatment Devices Production Capacity, Analysis
8.1 Global Congestive Heart Failure (CHF) Treatment Devices Production Capacity, 2017-2028
8.2 Congestive Heart Failure (CHF) Treatment Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Congestive Heart Failure (CHF) Treatment Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Congestive Heart Failure (CHF) Treatment Devices Supply Chain Analysis
10.1 Congestive Heart Failure (CHF) Treatment Devices Industry Value Chain
10.2 Congestive Heart Failure (CHF) Treatment Devices Upstream Market
10.3 Congestive Heart Failure (CHF) Treatment Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Congestive Heart Failure (CHF) Treatment Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com